Receptor Pharmacology
Receptor pharmacology explains how drugs interact with receptors to produce biological effects. This article covers agonists, antagonists, partial agonists, and dose-response relationships.
Drug-Receptor Interactions
Drugs produce their effects by binding to specific receptor sites. The nature of this binding determines the biological outcome.
Agonists
Agonists bind to receptors and activate them, producing a biological response. Full agonists produce the maximum possible response (Emax equals 100 percent).
Mnemonic: Agonists are “actors” — they step onto the receptor stage and perform the role, triggering the full biological script.
Antagonists
Antagonists bind to receptors but do not activate them. They block access by agonists, reducing or eliminating the biological response. Antagonists have affinity but no intrinsic activity (alpha equals 0).
Types of antagonists include:
- Competitive antagonists: Bind the same site as the agonist. Their effect can be overcome by increasing agonist concentration.
- Non-competitive antagonists: Bind a different site, reducing the maximum response regardless of agonist concentration.
Partial Agonists
Partial agonists bind receptors and produce a submaximal response. They have both affinity and limited intrinsic activity (alpha between 0 and 1). At high concentrations, partial agonists can actually reduce the effect of full agonists by competing for binding sites.
Inverse Agonists
Inverse agonists bind to receptors that have constitutive (basal) activity and reduce that activity below baseline. They are distinct from neutral antagonists, which simply block agonist effects without altering basal activity.
The Dose-Response Curve
The dose-response relationship describes how increasing drug concentration produces increasing biological effect. Key parameters include:
- EC50 (or ED50): The concentration (or dose) producing 50 percent of maximum effect. A lower EC50 indicates greater potency.
- Emax: The maximum effect achievable. A measure of efficacy.
- Therapeutic index: The ratio of toxic dose to therapeutic dose (TD50/ED50). A wider margin indicates greater safety.
Practical Applications
Understanding receptor pharmacology is essential for rational drug design. Selectivity between receptor subtypes reduces side effects. Partial agonists offer a safety ceiling in pain management. Inverse agonists are important in conditions where constitutive receptor activity contributes to disease.